ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 726444 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 726444; 2) Community: the network communities that were significantly associated with the response to NSC 726444; 3) Molecule: the relationships between components within communities and NSC 726444; 4) MDR: the compounds that were significantly associated with the NSC 726444.

NSC Compound Enrichment Correlation
NSC 674071 Null 0.0174563696971636 -0.16211108
NSC 674233 Null 0.0174563696971636 -0.16229802
NSC 676006 Null 0.0174563696971636 0.078715098
NSC 682789 Null 0.0174563696971636 0.36351233
NSC 692655 D-Homo-17a-aza-5-androsteno[17,16-c]pyrazol-3-yl,2'-(4-fluorophenyl)-, acetate 0.0174563696971636 0.2010313
NSC 707148 Card-20(22)-enolide, 3-[(6-deoxy-3-O-methyl-.beta.-D-galacto pyranosyl)oxy]-14-hydroxy-, (3.beta.,5.beta)- (9CI) 0.0174563696971636 0.47638129
NSC 707149 Card-20(22)-enolide, 16-(acetyloxy)-3-[(6-deoxy-3-O-methyl- .beta.-D-galactopyranosyl)oxy]-14-hydroxy-,(3.beta.,5.beta.,16.beta.)- (9CI) 0.0174563696971636 0.33833666
NSC 708244 Indolo[3,2-d]benzazepin-6(5H)-one, 9-cyano-2,3-dimethoxy-~7,12-dihydro- 0.0174563696971636 0.25165867
NSC 712411 Null 0.0174563696971636 0.21619822
NSC 729133 Null 0.0174563696971638 0.32471217
Total:91  Current:37    [First] [Prev] [Next] [Last]